We are live on ! Find out more
VTVT icon

vTv Therapeutics
VTVT

44 hedge funds and large institutions have $4.94M invested in vTv Therapeutics in 2020 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 14 increasing their positions, 7 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 7

56% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 9

13% more funds holding

Funds holding: 39 → 44 (+5)

0.09% less ownership

Funds ownership: 0.21% → 0.12% (-0.09%)

31% less capital invested

Capital invested by funds: $7.14M → $4.94M (-$2.2M)

Holders
44
Holders Change
+5
Holders Change %
+12.82%
% of All Funds
0.78%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
14
Reduced
7
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Ensign Peak Advisors
Ensign Peak Advisors
Utah
+$361K
2
Renaissance Technologies
Renaissance Technologies
New York
+$145K
3
BlackRock
BlackRock
New York
+$128K
4
VF
Virtu Financial
New York
+$72.2K
5
EGM
Engineers Gate Manager
New York
+$66.6K

Top Sellers

Rank Fund Capital Flow
1
FM
Frazier Management
Washington
-$1.88M
2
Two Sigma Investments
Two Sigma Investments
New York
-$889K
3
Two Sigma Advisers
Two Sigma Advisers
New York
-$829K
4
Wells Fargo
Wells Fargo
California
-$131K
5
GCP
GSA Capital Partners
United Kingdom
-$68K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$1.33M +$17.5K +228 +1%
BlackRock
2
BlackRock
New York
$818K +$128K +1,675 +18%
Ensign Peak Advisors
3
Ensign Peak Advisors
Utah
$350K +$361K +4,703 New
State Street
4
State Street
Massachusetts
$329K +$1.84K +24 +0.5%
Geode Capital Management
5
Geode Capital Management
Massachusetts
$316K +$1.84K +24 +0.6%
WAG
6
Winthrop Advisory Group
Massachusetts
$300K +$4.83K +63 New
Northern Trust
7
Northern Trust
Illinois
$262K +$7.05K +92 +3%
Renaissance Technologies
8
Renaissance Technologies
New York
$140K +$145K +1,888 New
Two Sigma Advisers
9
Two Sigma Advisers
New York
$87K -$829K -10,812 -90%
Vontobel Holding
10
Vontobel Holding
Switzerland
$84K +$86.3K +1,125 New
New York State Common Retirement Fund
11
New York State Common Retirement Fund
New York
$77K – – –
N
12
Nuveen
North Carolina
$77K – – –
VF
13
Virtu Financial
New York
$70K +$72.2K +942 New
EGM
14
Engineers Gate Manager
New York
$65K +$66.6K +868 New
Squarepoint
15
Squarepoint
New York
$61K -$153 -2 -0.2%
SFI
16
Susquehanna Fundamental Investments
Pennsylvania
$59K +$60.5K +789 New
Invesco
17
Invesco
Georgia
$55K +$56.9K +742 New
JP Morgan Chase
18
JP Morgan Chase
New York
$49K +$35.2K +459 +228%
Bank of New York Mellon
19
Bank of New York Mellon
New York
$43K -$2.38K -31 -5%
N
20
Natixis
France
$42K +$43.2K +563 New
Wells Fargo
21
Wells Fargo
California
$41K -$131K -1,707 -76%
Charles Schwab
22
Charles Schwab
California
$39K – – –
PPA
23
Parametric Portfolio Associates
Washington
$35K +$35.7K +466 New
OQS
24
Occudo Quantitative Strategies
Florida
$30K +$30.6K +399 New
California State Teachers Retirement System (CalSTRS)
25
California State Teachers Retirement System (CalSTRS)
California
$27K – – –
1
2 3

VTVT Hedge Fund Activity: Q4 2020 in Review

44 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in vTv Therapeutics (VTVT) for Q4 2020, worth a combined $4.94M — down 31% from $7.14M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new VTVT positions and 9 closed out — a net gain of 5 holders — while 14 added to existing stakes and 7 trimmed.

The largest buyer was Ensign Peak Advisors, opening a new position worth an estimated $361K. The largest seller was Frazier Management, exiting entirely with an estimated $1.88M sold.

  • 44 institutional investors held vTv Therapeutics (VTVT) as of Q4 2020, up from 39 in Q3 2020.
  • Funds reported $4.94M of vTv Therapeutics stock for Q4 2020, down 31% quarter-over-quarter.
  • 14 funds opened new vTv Therapeutics positions in Q4 2020 and 9 closed out, a net change of +5 holders.
  • The largest vTv Therapeutics buyer in Q4 2020 was Ensign Peak Advisors, an estimated $361K added.
  • The largest vTv Therapeutics seller in Q4 2020 was Frazier Management, an estimated $1.88M sold.

Based on aggregated 13F filings for Q4 2020.